Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Current Taxes (2016 - 2022)

Historic Current Taxes for Usana Health Sciences (USNA) over the last 10 years, with Q1 2022 value amounting to $11.3 million.

  • Usana Health Sciences' Current Taxes fell 940.35% to $11.3 million in Q1 2022 from the same period last year, while for Jan 2022 it was $11.3 million, marking a year-over-year decrease of 940.35%. This contributed to the annual value of $11.3 million for FY2022, which is 940.35% down from last year.
  • As of Q1 2022, Usana Health Sciences' Current Taxes stood at $11.3 million, which was down 940.35% from $12.5 million recorded in Q1 2021.
  • In the past 5 years, Usana Health Sciences' Current Taxes registered a high of $15.1 million during Q4 2018, and its lowest value of $10.2 million during Q4 2019.
  • For the 4-year period, Usana Health Sciences' Current Taxes averaged around $12.3 million, with its median value being $11.9 million (2021).
  • Its Current Taxes has fluctuated over the past 5 years, first crashed by 3192.96% in 2019, then surged by 2203.36% in 2021.
  • Quarter analysis of 4 years shows Usana Health Sciences' Current Taxes stood at $15.1 million in 2018, then plummeted by 31.93% to $10.2 million in 2019, then increased by 22.03% to $12.5 million in 2021, then fell by 9.4% to $11.3 million in 2022.
  • Its Current Taxes stands at $11.3 million for Q1 2022, versus $12.5 million for Q1 2021 and $10.2 million for Q4 2019.